elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46359097-B45AFD68-73C1-42A0-9CF8-C4B4CC4D305F
Q46359097-B45AFD68-73C1-42A0-9CF8-C4B4CC4D305F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46359097-B45AFD68-73C1-42A0-9CF8-C4B4CC4D305F
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
P698
Q46359097-B45AFD68-73C1-42A0-9CF8-C4B4CC4D305F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46359097-B45AFD68-73C1-42A0-9CF8-C4B4CC4D305F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee50308f1723bce5a047639e5c8e6bd71957af24
P698
18802150
http://www.w3.org/2001/XMLSchema#string